BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.07B+134% | $1.31B+4.9% | $1.25B+3.0% | $1.21B+15.7% | $1.05B+11.2% | ||
| $0-100% | $248.93M+9.3% | $227.73M+4.3% | $218.31M-2.3% | $223.53M+14.7% | ||
| $903.91M-0.5% | $908.21M+14.9% | $790.27M-7.7% | $855.86M+15.8% | $739.18M+11.9% | ||
| $1.27B-2.0% | $1.3B-6.0% | $1.38B+3.1% | $1.34B+5.1% | $1.27B+3.4% | ||
| $4.61B+16.5% | $3.95B+2.6% | $3.85B+1.3% | $3.81B+9.7% | $3.47B+7.3% | ||
| $958.07M+0.6% | $952.51M-8.3% | $1.04B+0.8% | $1.03B-0.2% | $1.03B-1.0% | ||
| $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $204.66M-4.3% | $213.84M-8.3% | $233.11M-2.7% | $239.62M-3.1% | $247.35M-3.1% | ||
| $8.59B+13.1% | $7.59B-0.3% | $7.61B+2.1% | $7.46B+4.3% | $7.15B+2.3% | ||
| $793.15M+4.5% | $759.03M-4.9% | $798.44M+16.7% | $684.25M+8.9% | $628.21M+3.5% | ||
| $793.15M+4.5% | $759.03M-4.9% | $798.44M+16.7% | $684.25M+8.9% | $628.21M+3.5% | ||
| $1.43B+140% | $597.18M-0.5% | $600M0.0% | $600M0.0% | $600M— | ||
| $2.38B+57.9% | $1.51B-3.3% | $1.56B+9.0% | $1.43B+5.6% | $1.35B+1.7% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+261,680% | ||
| $259.73M+68.4% | $154.21M-23.2% | $200.78M-13.3% | $231.52M+2,670% | -$9.01M+95.4% | ||
| $6.21B+2.1% | $6.09B+0.5% | $6.06B+0.5% | $6.03B+4.0% | $5.79B+2.4% | ||
| $8.59B+13.1% | $7.59B-0.3% | $7.61B+2.1% | $7.46B+4.3% | $7.15B+2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $8.6B in total assets, up 20.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $1.4B in total debt against $6.2B of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $3.1B in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
